• menu
    Market Place Market Place
    Sourcing support Sourcing Support
    API / FDF
    Excipients
    Services
    Developments
    News
    Market Intel
    #Phispers
    #SpeakPharma
    #LearnMore

    NEWS

    DRUGS & DEVELOPMENTS

    MARKET INTEL by PharmaCompass

    Mission CDMO team brings reliability, resourcefulness, & responsiveness in executing your development project.

    Bionpharma`s Generic Doxylamine Succinate, Pyridoxine Hydrochloride Receives Approval in the U.S.

    FDA

    Actavis Labs` Generic Doxylamine Succinate and Pyroxidine Hydrochloride Receives Approval in the U.S.

    FDA

    Enforcement Report - Week of February 9, 2022

    FDA

    Class 4 Medicine Defect Information: Xonvea 10 mg/10 mg gastro-resistant tablets

    MHRA

    FDA Confirms Paragraph IV Patent Challenge of Bonjesta 209661 (Doxylamine Succinate and Pyridoxine Hydrochloride) Extended-release Tablets

    FDA

    Updated List of New Paragraph IV Patent Certifications - Oct 22

    FDA

    Duchesnay USA Announces Launch Bonjesta®doxylamine succinate, pyridoxine HCL)

    PR NEWSWIRE

    Par Pharm’s Generic Doxylamine Succinate; Pyridoxine HCL Receives Approval In US

    FDA

    Kim Kardashian flouts FDA warning AGAIN to promote `dangerous` sickness pill

    DAILYMAIL

    Actavis Receives FDA Approval for Doxylamine Succinate

    FDA

    Want to get a warning letter from OPDP?Omit drug risk from your promos

    FIERCE PHARMA MARKETING

    Kim Kardashian posts drug’s side effects after FDA warning

    NEW YORK POST

    Duchesnay USA Publishes Corrective Messaging through Kim Kardashian’s Social Media Accounts in Response to FDA’s Request

    DUCHESNAY USA

    Has Kim Kardashian ruined pharma marketing, too? Fallout from the infamous Instagram post

    FIERCE PHARMA MARKETING

    Diclegis® For Morning Sickness Now Available In Puerto Rico

    DUCHESNAY USA

    Copyright © 2024 LePro PharmaCompass OPC Private Limited, All rights reserved.